New therapies shaping the future of amyloidosis
A summary of lymphoma immune checkpoint inhibitor data at EHA 2017
Introduction to the BSH/ISH conference
Providing novel treatments and standardising CLL biomarker testing across the world
Is the CR of MM patients a good objective for treatment?